1,170 results on '"Colitis, ulcerative"'
Search Results
2. Entyvio (Vedolizumab) Long Term Safety Study (Entyvio PASS)
3. A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (PURSUIT 2)
4. A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis (Horizon)
5. A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (ASTRO)
6. A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
7. A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease (RELIEVE UCCD)
8. A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis (DUET-UC)
9. A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants (TRILOGY)
10. Role of Bile Acids and Microbiota in Clostridioides Difficile Infection in Ulcerative Colitis (ABRICO)
11. Phase 1 Study Evaluating PALI-2108 in Healthy Volunteers and Ulcerative Colitis Patients.
12. Comparison of Medical RESCUE Strategies for Patients With Steroid-refractory Acute Severe Ulcerative Colitis (RESCUE UC)
13. A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis (ANTHEM-UC)
14. Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis
15. VE202 in Patients with Mild-to-Moderate Ulcerative Colitis
16. Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
17. A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
18. A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis (EFFECT-UC)
19. An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis (ENDEAVOUR-UC)
20. Enabling Microbiomics- Driven Personalized Nutrition (EMPOWER)
21. A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC) (UNIFI Jr)
22. Immune Regulation in Ulcerative Colitis or Crohn s Disease
23. Family Members at INcreased-risk for Developing Inflammatory Bowel Disease (FIND-IBD)
24. A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis (SHINE-2)
25. A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (QUASAR Jr)
26. LMT503 First-in-human SAD, MAD, and FE Study
27. Maresin-1 and Resolvin-D1 Levels and Disease Activity in Ulcerative Colitis
28. Gluten-free Diet in PSC and IBD
29. Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis (PALEKONA)
30. A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))
31. Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.
32. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)
33. Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis (SWIFT)
34. A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
35. Virtual Reality Headset and Acceptability of Rectosigmoidoscopy in Ulcerative Colitis: a Randomised Controlled Trial (VIRTU)
36. A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis
37. A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
38. A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005) (ARTEMIS-UC)
39. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World Practice (VARIETY-AUT)
40. Evaluation of ProLife 10 FORTE on Gut Microbiota Composition in UC Patients (ProZ-UC)
41. A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
42. Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
43. A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
44. Chronotherapy of 5-Aminosalicylic Acid in Ulcerative Colitis
45. Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis (RESOLUTE)
46. A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) (SHINE-ON)
47. A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
48. Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis
49. A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
50. An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis (OPAL)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.